Help us make childhood cancer universally survivable.

By giving monthly, you directly support our continued research into discovering effective and less toxic treatments for childhood cancer.

Support Our Lab

Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

I want to dedicate this donation to someone

In honor of... Details

Donation Total: $25.00 One Time

Our team is on a mission to make childhood cancer universally survivable!

The FDA approves on average 12 drugs every year to treat adult cancer, but has only approved 10 drugs to treat childhood cancer since 1978 (10 in 44 years for kids).

Since our inception in 2015, cc-TDI has pushed two drugs into three clinical trials to treat childhood cancer.

giving back childhood for


Latest News

Newly Published Studies Suggest a Framework for RMS Drug Development

We are thrilled to announce a new publication, Structure-activity relationship of dihydropyridines for rhabdomyosarcoma, showcasing results of a study of a massive drug & chemical screen for the childhood muscle cancer, rhabdomyosarcoma (RMS), in the journal Biochemical and Biophysical Research Communications. Rhabdomyosarcoma (RMS) is the most common soft tissue tumor in children with approximately 400 cases detected per year in the United States. The World Health Organization recognizes three major categories of RMS based on histological features, i.e., alveolar, embryonal, pleomorphic and spindle cell sclerosing RMS. Alveolar and embryonal RMS are the most common types

Read More »

Current Research Projects

A dedicated research team

Our research team is exploring and testing state-of-the-art treatment options for the most urgent issues facing children with cancer. 

Working in our own freestanding research institution allows us to act swiftly and nimbly to achieve results—bringing cost control, speed, purpose, and focus to translate effective treatments into the clinic. To get there, we perform basic science and translational research in our industrial modern lab site (a paint factory remodeled by Nike as an off-site creative space), adjacent to the Silicon Forest in Oregon.